Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

Invitation to Invest in Australia’s Most Exciting Cannabis Company

  • Published March 20, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Recently the Founder of the Oz Medicann Group (OMG), John Leith launched the Series B capital raise with a cash injection of $600k. With increased revenues this financial year OMG will move from Early Stage Innovation to accelerated Growth. OMG’s impressive track record of bringing products to market, building brand awareness and customer loyalty and market ready innovative products will ensure future success and expansion into the global market.

OMG’s unique offering brings together patient centred health care, wellness and education. As an investor you will see the rewards of an integrated model which offers a number of revenue streams and opportunities in international markets. OMG has a diversified distribution model with over 3000 on line members, on-line sales and products in 350+ stockists across Australia.

Invest before June 30, 2020 to ensure that you maximise your investment through the ESIC Incentive program.

Register Interest

About Oz Medicann

OMG is a licenced patient-centric medicinal cannabis and hemp wellness company with a key focus on research, product development, education, cultivation and GMP standard manufacturing.

OMG is a diversified portfolio of companies comprising Oz Medicann Pharma, Educann and Hemp Oz and is supported by a team of medical practitioners, business leaders, marketing, sales and distribution expertise and innovation in new medicine.

Register Interest

Company Updates
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!

In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]

Capital Insights
Ecosystems Over Exit: Callum Laing on Disrupting Small Business M&A

At Emergence Singapore, Callum Laing of Veblen Director Program presented a bold new vision for small business M&A: “Ecosystems Over Exit.” He shared how his Unity Group takes cash-generating businesses public, focusing on growth over immediate founder exit. Discover his unique approach, how interconnected ecosystems drive massive deal flow, and a three-step framework for any business to amplify reach and capital raising.

Capital Insights
Report on the Impact of the Proposed Unrealised Capital Gains Tax on Investment in Key Sectors

A recent survey of investors and company leaders reveals significant concerns about the proposed Unrealised Capital Gains Tax (UCGT) in Australia. Over 84% indicate it would negatively impact investment in vital renewable energy, sustainability, and life science sectors, with 82% believing it would discourage long-term holdings. The report highlights the critical role of SMSF investors in early-stage funding and urges policymakers to reconsider the tax’s potential to stifle innovation and economic growth.

Join over 45,000+ sophisticated investors

Join Now